Share
Economic uncertainty has dampened the anticipated digital health M&A momentum for early 2025, but the sector is still far from stagnant. While larger deals and IPOs have largely paused, there have still been smaller, strategic acquisitions continuing to push forward. This signals that investors are recalibrating—not retreating—and using this phase to strengthen fundamentals and focus on value creation.
In
Modern Healthcare's recent article,
Brad Kuntz, Senior Managing Director, discussed how potential acquirers are seeking for clarity on more volatile aspects such as interest rates and the extent to which businesses will be impacted by tariffs.
Read More
A recap of Grant Thornton Stax and Raymond James’ healthcare breakfast on PE investment opportunities across the pharma tech ecosystem.
AI is driving a bifurcation between surface-layer productivity tools and core operational platforms within vertical software. Learn how Ai is reshaping vertical SaaS here.
For four straight years, Grant Thornton Stax has earned a spot on the Vault Consulting Top 50 list of the best consulting firms to work for in North America. Read more here.
Grant Thornton Stax supported Alma, a membership-based platform that aids mental health clinicians in building thriving private practices, on its recent acquisition by Spring Health. Read more.
Grant Thornton Stax is pleased to announce our 2026 winter promotions. Click to learn more.
Grant Thornton Stax Consultant Chris Flynn sits down for a Q&A to share his experience and insights from his tenure with our firm. Read the full interview here.